期刊文献+

5-氟尿嘧啶联合奥沙利铂术前短程冲击化疗大肠癌的效果观察

Observation Impact Effect of 5-Fluorouracil Combined With Oxaliplatin Chemotherapy For Colorectal Cancer Preoperative Short-Range
下载PDF
导出
摘要 目的探究与分析5-氟尿嘧啶联合奥沙利铂术前短程冲击化疗大肠癌的临床效果。方法选取我院收治的90例大肠癌患者采取随机数字表法分为对照组与观察组,每组45例,对照组术前不接受任何抗肿瘤治疗,常规准备后给予根治性手术,观察组手术前给予5-氟尿嘧啶联合奥沙利铂术前短程冲击化疗,3 d后给予根治性手术,对比两组临床疗效。结果对照组临床总有效率为44.44%,观察组临床总有效率为55.56%,观察组与对照组相比,临床总有效率较高,差异具有统计学意义(P<0.05)。结论 5-氟尿嘧啶联合奥沙利铂术前短程冲击化疗大肠癌的效果显著。 Objective With the analysis of the clinical effect of five fluorouracil combined with oxaliplatin chemotherapy for colorectal cancer preoperative short-range impact to explore. Methods 90 cases of colorectal cancer in our hospital were randomly divided into control group and observation group,45 cases in each group,the control group did not receive any anticancer therapy before operation,routine preparation after radical surgery,the observation group before surgery to five fluorouracil combined with oxaliplatin in preoperative chemotherapy after 3 days of short-range impact. Given radical surgery,compared two groups of clinical curative effect. Results The total effective rate of the control group was 44.44%,the observation group was 55.56%,the total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P〈0.05). Conclusion Five fluorouracil combined with oxaliplatin chemotherapy for colorectal cancer preoperative shortrange impact effect.
作者 谭斌
出处 《中国继续医学教育》 2016年第34期154-156,共3页 China Continuing Medical Education
关键词 5-氟尿嘧啶 奥沙利铂 术前短程冲击 大肠癌 5-Fluorouracil Oxaliplatin Preoperative short-term impact Colorectal cancer
  • 相关文献

参考文献7

二级参考文献69

  • 1季加孚.胃癌外科的现状与发展趋势[J].中国普外基础与临床杂志,2006,13(1):1-3. 被引量:65
  • 2沈历宗,吴文溪,华一兵,王国梁.腹腔镜直肠肿瘤根治手术的临床应用及体会[J].中国内镜杂志,2006,12(5):478-480. 被引量:3
  • 3周建凤,陈书长.FOLFOX4方案一线治疗晚期大肠癌近期疗效分析[J].癌症进展,2006,4(5):452-455. 被引量:6
  • 4汤钊献.现代肿瘤学[M].上海:上海医科大学出版社,1993.675-680.
  • 5Abdel-Misih SR,Schmidt CR,Bloomston PM.Update and review of the multidisciplinary management of stage Ⅳ colorectal cancer with liver metastases.World J Surg Oncol,2009,7:72.
  • 6Cantero-Muoz P,Urién MA,Ruano-Ravina A.Efficacy and safety of intraoperative radiotherapy in colorectal cancer:A systematic review.Cancer Lett,2011,306:121-133.
  • 7Gruenberger B,Tamandl D,Schueller J,et al.Bevacizumab,capecitabine,and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.J Clin Oncol,2008,26:1830-1835.
  • 8Pozzo C,Barone C,Kemeny NE.Advances in neoadjuvant therapy for colorectal cancer with liver metastases.Cancer Treat Rev,2008,34:293-301.
  • 9Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada.J Natl Cancer Inst,2000,92:205-216.
  • 10Tsuchida Y,Therasse P.Response evaluation criteria in solid tumors (RECIST):new guidelines.Med Pediatr Oncol,2001,37:1-3.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部